These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 2543286

  • 1. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations.
    Low DE, McGeer A, Poon R.
    Antimicrob Agents Chemother; 1989 Apr; 33(4):585-8. PubMed ID: 2543286
    [Abstract] [Full Text] [Related]

  • 2. Susceptibility of Staphylococcus species and subspecies to teicoplanin.
    Bannerman TL, Wadiak DL, Kloos WE.
    Antimicrob Agents Chemother; 1991 Sep; 35(9):1919-22. PubMed ID: 1835340
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
    Del' Alamo L, Cereda RF, Tosin I, Miranda EA, Sader HS.
    Diagn Microbiol Infect Dis; 1999 Jul; 34(3):185-91. PubMed ID: 10403098
    [Abstract] [Full Text] [Related]

  • 4. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci.
    Shonekan D, Mildvan D, Handwerger S.
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1570-2. PubMed ID: 1324649
    [Abstract] [Full Text] [Related]

  • 5. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins. A retrospective and prospective national surveillance trial of isolates from 40 medical centers.
    Jones RN, Barry AL, Gardiner RV, Packer RR.
    Diagn Microbiol Infect Dis; 1989 Jul; 12(5):385-94. PubMed ID: 2533050
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility Profile of Staphylococcus epidermidis and Staphylococcus haemolyticus Isolated from Blood Cultures to Vancomycin and Novel Antimicrobial Drugs over a Period of 12 Years.
    Pinheiro L, Brito CI, Pereira VC, Oliveira A, Bartolomeu AR, Camargo CH, Cunha ML.
    Microb Drug Resist; 2016 Jun; 22(4):283-93. PubMed ID: 26623676
    [Abstract] [Full Text] [Related]

  • 7. Glycopeptide susceptibility profiles of nosocomial multiresistant Staphylococcus haemolyticus isolates.
    Tabe Y, Nakamura A, Igari J.
    J Infect Chemother; 2001 Sep; 7(3):142-7. PubMed ID: 11810575
    [Abstract] [Full Text] [Related]

  • 8. In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile.
    Bartoloni A, Colao MG, Orsi A, Dei R, Giganti E, Parenti F.
    J Antimicrob Chemother; 1990 Nov; 26(5):627-33. PubMed ID: 1688341
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of the new glycopeptide decaplanin.
    Neu HC, Chin NX, Niu WW.
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):458-62. PubMed ID: 1330562
    [Abstract] [Full Text] [Related]

  • 10. Comparative in vitro activity of teicoplanin and vancomycin against United States teicoplanin clinical trial isolates of gram-positive cocci.
    Kenny MT, Dulworth JK, Brackman MA.
    Diagn Microbiol Infect Dis; 1991 May; 14(1):29-31. PubMed ID: 1826479
    [Abstract] [Full Text] [Related]

  • 11. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci.
    Goldstein FW, Coutrot A, Sieffer A, Acar JF.
    Antimicrob Agents Chemother; 1990 May; 34(5):899-900. PubMed ID: 2141780
    [Abstract] [Full Text] [Related]

  • 12. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates.
    Biavasco F, Vignaroli C, Lazzarini R, Varaldo PE.
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3122-6. PubMed ID: 11036034
    [Abstract] [Full Text] [Related]

  • 13. Quality control limits for teicoplanin susceptibility tests and confirmation of disk diffusion interpretive criteria.
    Barry AL, Jones RN, Gavan TL, Thornsberry C.
    J Clin Microbiol; 1987 Sep; 25(9):1812-4. PubMed ID: 2958498
    [Abstract] [Full Text] [Related]

  • 14. Selection of vancomycin- and teicoplanin-resistant Staphylococcus haemolyticus during teicoplanin treatment of S. epidermidis infection.
    Aubert G, Passot S, Lucht F, Dorche G.
    J Antimicrob Chemother; 1990 Mar; 25(3):491-3. PubMed ID: 2140112
    [No Abstract] [Full Text] [Related]

  • 15. Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States.
    Jones RN, Goldstein FW, Zhou XY.
    Antimicrob Agents Chemother; 1991 Mar; 35(3):584-6. PubMed ID: 1828137
    [Abstract] [Full Text] [Related]

  • 16. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species.
    Biavasco F, Giovanetti E, Montanari MP, Lupidi R, Varaldo PE.
    J Antimicrob Chemother; 1991 Jan; 27(1):71-9. PubMed ID: 1828799
    [Abstract] [Full Text] [Related]

  • 17. In-vitro susceptibility of gram-positive cocci to LY146032 teicoplanin, sodium fusidate, vancomycin, and rifampicin.
    Pohlod DJ, Saravolatz LD, Somerville MM.
    J Antimicrob Chemother; 1987 Aug; 20(2):197-202. PubMed ID: 2822646
    [Abstract] [Full Text] [Related]

  • 18. In-vitro induction of resistance in coagulase-negative staphylococci to vancomycin and teicoplanin.
    Watanakunakorn C.
    J Antimicrob Chemother; 1988 Sep; 22(3):321-4. PubMed ID: 2972670
    [Abstract] [Full Text] [Related]

  • 19. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M, Hidalgo Orozco R, Rodríguez Garrido S, Gaona Álvarez C, Sánchez Silos RM, Hernández Rastrollo R, Martínez Tallo E, Cordero Carrasco JL.
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [Abstract] [Full Text] [Related]

  • 20. Comparative in vitro activity of LY146032 (daptomycin), a new lipopeptide antimicrobial.
    Hodinka RL, Jack-Wait K, Wannamaker N, Walden TP, Gilligan PH.
    Eur J Clin Microbiol; 1987 Feb; 6(1):100-3. PubMed ID: 3032607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.